Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NEGATIVE BREAST-CANCER' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 181 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Duffy, MJ
      Clinical uses of tumor markers: A critical review

      CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
    2. Gaci, Z; Bouin-Pineau, MH; Gaci, M; Daban, A; Ingrand, P; Metaye, T
      Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup ofnode-negative breast cancer patients with low histological grade tumors

      INTERNATIONAL JOURNAL OF ONCOLOGY
    3. Chen, Y; Emtage, P; Zhu, Q; Foley, R; Muller, W; Hitt, M; Gauldie, J; Wan, Y
      Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12

      GENE THERAPY
    4. Carpenter, R
      Sentinel node biopsy should be introduced into routine practice before results of randomized trials are available

      BREAST
    5. Cooke, T; Reeves, J; Lannigan, A; Stanton, P
      The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker

      EUROPEAN JOURNAL OF CANCER
    6. van de Vijver, MJ
      Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2)

      EUROPEAN JOURNAL OF CANCER
    7. Valagussa, P
      HER2 status: A statistician's view

      ANNALS OF ONCOLOGY
    8. Yazici, H; Altun, M; Hafiz, G; Dalay, N
      Serum and tissue c-erb B2, bcl-2, and mutant p53 oncoprotein levels in nasopharyngeal cancer

      CANCER INVESTIGATION
    9. Keshtgar, MRS; Baum, M
      Axillary dissection over the years: Where to from here?

      WORLD JOURNAL OF SURGERY
    10. Colpaert, C; Vermeulen, P; van Beest, P; Goovaerts, G; Weyler, J; Van Dam, P; Dirix, L; Van Marck, E
      Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breastcancer patients

      HISTOPATHOLOGY
    11. Wakui, S; Muto, T; Yokoo, K; Yokoo, R; Takahashi, H; Masaoka, T; Hano, H; Furusato, M
      Prognostic status of p53 gene mutation in canine mammary carcinoma

      ANTICANCER RESEARCH
    12. Wersto, RP; Chrest, FJ; Leary, JF; Morris, C; Stetler-Stevenson, M; Gabrielson, E
      Doublet discrimination in DNA cell-cycle analysis

      CYTOMETRY
    13. Kato, T; Kameoka, S; Kimura, T; Nishikawa, T; Kasajima, T
      Angiogenesis and blood vessel invasion as prognostic indicators for node-negative breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    14. Daidone, MG; Costa, A; Silvestrini, R
      Cell proliferation markers in human solid tumors: Assessing their impact in clinical oncology

      METHODS IN CELL BIOLOGY, VOL 64
    15. Cvetkovic, D; Movsas, B; Dicker, AP; Hanlon, AL; Greenberg, RE; Chapman, JD; Hanks, GE; Tricoli, JV
      Increased hypoxia correlates with increased expression of the angiogenesismarker vascular endothelial growth factor in human prostate cancer

      UROLOGY
    16. Nio, Y; Dong, M; Iguchi, C; Yamasawa, K; Toga, T; Itakura, M; Tamura, K
      Expression of Bcl-2 and p53 protein in resectable invasive ductal carcinoma of the pancreas: Effects on clinical outcome and efficacy of adjuvant chemotherapy

      JOURNAL OF SURGICAL ONCOLOGY
    17. Colpaert, C; Vermeulen, P; Jeuris, W; van Beest, P; Goovaerts, G; Weyler, J; Van Dam, P; Dirix, L; Van Marck, E
      Early distant relapse in 'node-negative' breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of theprimary tumour

      JOURNAL OF PATHOLOGY
    18. Jordan, VC
      Selective estrogen receptor modulation: A personal perspective

      CANCER RESEARCH
    19. Coradini, D; Boracchi, P; Daidone, MG; Pellizzaro, C; Miodini, P; Ammatuna, M; Tomasic, G; Biganzoli, E
      Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer

      BRITISH JOURNAL OF CANCER
    20. Wong, SL; Edwards, MJ; Chao, C; Tuttle, TM; Noyes, RD; Woo, C; Cerrito, PB; McMasters, KM
      Predicting the status of the nonsentinel axillary nodes a - Multicenter study

      ARCHIVES OF SURGERY
    21. O'Malley, FP; Parkes, R; Latta, E; Tjan, S; Zadro, T; Mueller, R; Arneson, N; Blackstein, M; Andrulis, I
      Comparison of HER2/neu status assessed by quantitative polymerase chain reaction and immunohistochemistry

      AJCP. American journal of clinical pathology
    22. Love, RR; Kurtycz, DF; Dumesic, DA; Laube, DW; Yang, TGF
      The effects of tamoxifen on the vaginal epithelium in postmenopausal women

      JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
    23. Ohmura, Y; Aoe, M; Andou, A; Shimizu, N
      Telomerase activity and Bcl-2 expression in non-small cell lung cancer

      CLINICAL CANCER RESEARCH
    24. Nienaber, VL; Davidson, D; Edalji, R; Giranda, VL; Klinghofer, V; Henkin, J; Magdalinos, P; Mantei, R; Merrick, S; Severin, JM; Smith, RA; Stewart, K; Walter, K; Wang, JY; Wendt, M; Weitzberg, M; Zhao, XM; Rockway, T
      Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite

      STRUCTURE WITH FOLDING & DESIGN
    25. Asgeirsson, KS; Jonasson, JG; Tryggvadottir, L; Olafsdottir, K; Sigurgeirsdottir, JR; Ingvarsson, S; Ogmundsdottir, HM
      Altered expression of E-cadherin in breast cancer: patterns, mechanisms and clinical significance

      EUROPEAN JOURNAL OF CANCER
    26. Meng, TC; Lee, MS; Lin, MF
      Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells

      ONCOGENE
    27. Silvestrini, R
      Relevance of DNA-ploidy as a prognostic instrument for solid tumors

      ANNALS OF ONCOLOGY
    28. DiFrancesco, LM; Murthy, SK; Luider, J; Demetrick, DJ
      Laser capture microdissection-guided fluorescence in situ hybridization and flow cytometric cell cycle analysis of purified nuclei from paraffin sections

      MODERN PATHOLOGY
    29. Rickert, D; Mittermayer, C; Lindenfelser, R; Biesterfeld, S
      MIB-1 immunohistometry of follicular adenoma and follicular carcinoma of the thyroid gland

      ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    30. Breuer, B; Anderson, R
      The relationship of tamoxifen with dementia, depression, and dependence inactivities of daily living in elderly nursing home residents

      WOMEN & HEALTH
    31. Bayerlein, K; Rith, T; Verdorfer, I; Liehr, T; Wolff, E; Girod, S; Gebhart, E
      I-FISH control of CGH-detected gain of DNA sequence copy number in oral squamous cell carcinomas (OSCC)

      ANTICANCER RESEARCH
    32. Dahm-Daphi, J
      p53: Biology and role for cellular radiosensitivity

      STRAHLENTHERAPIE UND ONKOLOGIE
    33. Volpi, A; De Paola, F; Nanni, O; Granato, AM; Bajorko, P; Becciolini, A; Scarpi, E; Riccobon, A; Balzi, M; Amadori, D
      Prognostic significance of biologic markers in node-negative breast cancerpatients: a prospective study

      BREAST CANCER RESEARCH AND TREATMENT
    34. Gregory, RK; Powles, TJ; Salter, J; Chang, JC; Ashley, S; Dowsett, M
      Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy

      BREAST CANCER RESEARCH AND TREATMENT
    35. Busse, D; Doughty, RS; Arteaga, CL
      HER-2/neu (erbB-2) and the cell cycle

      SEMINARS IN ONCOLOGY
    36. Scholzen, T; Gerdes, J
      The Ki-67 protein: From the known and the unknown

      JOURNAL OF CELLULAR PHYSIOLOGY
    37. Earle, CC; Venditti, LN; Neumann, PJ; Gelber, RD; Weinstein, MC; Potosky, AL; Weeks, JC
      Who gets chemotherapy for metastatic lung cancer?

      CHEST
    38. Ferrier, CM; Suciu, S; van Geloof, WL; Straatman, H; Eggermont, AMM; Koops, HS; Kroon, BBR; Lejeune, FJ; Kleeberg, UR; van Muijen, GNP; Ruiter, DJ
      High tPA-expression in primary melanoma of the limb correlates with good prognosis

      BRITISH JOURNAL OF CANCER
    39. Kato, T; Kimura, T; Miyakawa, R; Fujii, A; Yamamoto, K; Kameoka, S; Nishikawa, T; Kasajima, T
      Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer

      BRITISH JOURNAL OF CANCER
    40. Orr, MS; O'Connor, PM; Kohn, KW
      Effects of c-erbB2 overexpression on the drug sensitivities of normal human mammary epithelial cells

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    41. Hoffmann, G; Pollow, K; Weikel, W; Strittmatter, HJ; Bach, J; Schaffrath, M; Knapstein, P; Melchert, F; Pollow, B
      Urokinase and plasminogen activator-inhibitor (PAI-1) status in primary ovarian carcinomas and ovarian metastases compared to benign ovarian tumors as a function of histopathological parameters

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    42. Ross, JS; Fletcher, JA
      The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy

      SEMINARS IN CANCER BIOLOGY
    43. Harbeck, N; Ross, JS; Yurdseven, S; Dettmar, P; Polcher, M; Kuhn, W; Ulm, K; Graeff, H; Schmitt, M
      HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    44. Baekelandt, M; Holm, R; Trope, CG; Nesland, JM; Kristensen, GB
      The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer

      ANNALS OF ONCOLOGY
    45. Rungsipipat, A; Tateyama, S; Yamaguchi, R; Uchida, K; Miyoshi, N; Hayashi, T
      Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors

      JOURNAL OF VETERINARY MEDICAL SCIENCE
    46. Jaattela, M
      Heat shock proteins as cellular lifeguards

      ANNALS OF MEDICINE
    47. Hall, PA; Going, JJ
      Predicting the future: a critical appraisal of cancer prognosis studies

      HISTOPATHOLOGY
    48. Spath, HM; Carrere, MO; Fervers, B; Philip, T
      Analysis of the eligibility of published economic evaluations for transferto a given health care system - Methodological approach and application tothe French health care system

      HEALTH POLICY
    49. Muller-Hocker, J
      Immunoreactivity of p53, Ki-67, and bcl-2 in oncocytic adenomas and carcinomas of the thyroid gland

      HUMAN PATHOLOGY
    50. Wong, SWJ; Rangan, AM; Bilous, AM; Boyages, J; Gebski, V; Benson, EM
      The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting

      PATHOLOGY
    51. Kaufman, CS
      Another view of the Tamoxifen Trial

      JOURNAL OF SURGICAL ONCOLOGY
    52. Duffy, MJ; Maguire, TM; McDermott, EW; O'Higgins, N
      Urokinase plasminogen activator: A prognostic marker in multiple types of cancer

      JOURNAL OF SURGICAL ONCOLOGY
    53. Jaattela, M
      Escaping cell death: Survival proteins in cancer

      EXPERIMENTAL CELL RESEARCH
    54. Fukuiwa, T; Takebayashi, Y; Akiba, S; Matsuzaki, T; Hanamure, Y; Miyadera, K; Yamada, Y; Akiyama, S
      Expression of thymidine phosphorylase and vascular endothelial cell growthfactor in human head and neck squamous cell carcinoma and their different characteristics

      CANCER
    55. Huuhtanen, RL; Blomqvist, CP; Wiklund, TA; Bohling, TO; Virolainen, MJ; Tukiainen, EJ; Tribukait, B; Andersson, LC
      Comparison of the Ki-67 score and S-phase fraction as prognostic variablesin soft tissue sarcoma

      BRITISH JOURNAL OF CANCER
    56. Falcon, O; Chirino, R; Leon, L; Lopez-Bonilla, A; Torres, S; Fernandez, L; Garcia-Hernandez, JA; Valeron, PF; Diaz-Chico, JC
      Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer

      BRITISH JOURNAL OF CANCER
    57. Karrison, TG; Ferguson, DJ; Meier, P
      Dormancy of mammary carcinoma after mastectomy

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    58. STOMPER PC; DEBLOOM JR; LEVINE E; BUDNICK RM; STEWART CC
      FLOW CYTOMETRIC DNA ANALYSIS OF INVASIVE CARCINOMAS DETECTED BY SCREENING MAMMOGRAPHY - USE OF SPECIMEN MAMMOGRAPHY-GUIDED FINE-NEEDLE ASPIRATES

      Clinical cancer research
    59. LENZ HJ; DANENBERG KD; LEICHMAN CG; FLORENTINE B; JOHNSTON PG; GROSHEN S; ZHOU LY; XIONG YP; DANENBERG PV; LEICHMAN LP
      P53 AND THYMIDYLATE SYNTHASE EXPRESSION IN UNTREATED STAGE-II COLON-CANCER - ASSOCIATIONS WITH RECURRENCE, SURVIVAL, AND SITE

      Clinical cancer research
    60. LENZ HJ; DANENBERG KD; LEICHMAN CG; FLORENTINE B; JOHNSTON PG; GROSHEN S; ZHOU LY; XIONG YP; DANENBERG PV; LEICHMAN LP
      P53 AND THYMIDYLATE SYNTHASE EXPRESSION IN UNTREATED STAGE-II COLON-CANCER - ASSOCIATIONS WITH RECURRENCE, SURVIVAL, AND SITE

      Clinical cancer research
    61. LENZ HJ; HAYASHI K; SALONGA D; DANENBERG KD; DANENBERG PV; METZGER R; BANERJEE D; BERTINO JR; GROSHEN S; LEICHMAN LP; LEICHMAN CG
      P53 POINT MUTATIONS AND THYMIDYLATE SYNTHASE MESSENGER-RNA LEVELS IN DISSEMINATED COLORECTAL-CANCER - AN ANALYSIS OF RESPONSE AND SURVIVAL

      Clinical cancer research
    62. LENZ HJ; HAYASHI K; SALONGA D; DANENBERG KD; DANENBERG PV; METZGER R; BANERJEE D; BERTINO JR; GROSHEN S; LEICHMAN LP; LEICHMAN CG
      P53 POINT MUTATIONS AND THYMIDYLATE SYNTHASE MESSENGER-RNA LEVELS IN DISSEMINATED COLORECTAL-CANCER - AN ANALYSIS OF RESPONSE AND SURVIVAL

      Clinical cancer research
    63. MA L; RONAI A; RIEDE UN; KOHLER G
      EXPRESSION OF P53 AND BCL-2 IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - AN IMMUNOHISTOCHEMICAL STUDY

      Applied immunohistochemistry
    64. WELLHAUSEN L; SAEGER W; MULLER W; DERWAHL M; HAMACHER C; LUDECKE DK
      GS-ALPHA, PROTEIN-KINASE-C, CATHEPSIN-D, GROWTH-FACTORS, ESTROGEN RECEPTOR-RELATED PROTEIN, AND P53 IN PROLACTIN CELL ADENOMAS AND NULL-CELL ADENOMAS OF THE PITUITARY

      Endocrine pathology
    65. ELLIS LM; WALKER RA; GASPARINI G
      IS DETERMINATION OF ANGIOGENIC ACTIVITY IN HUMAN TUMORS CLINICALLY USEFUL

      European journal of cancer
    66. Berger, K; Fischer, T; Szucs, TD
      Cost-effectiveness analysis of paclitaxel acid cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective

      EUROPEAN JOURNAL OF CANCER
    67. BIESTERFELD S; HOFFMANN E
      MIB-1 IMMUNOHISTOMETRY ON TRU-CUT BIOPSIES IN INFLAMMATORY AND CIRRHOTIC LIVER-DISEASE

      Analytical and quantitative cytology and histology
    68. HALLAK R; LOTTER O; SAFI F; JOUMA M
      EVALUATION OF AN IMMUNOLUMINOMETRIC BASED ASSAY AS A NOVEL METHOD FORTHE QUANTITATIVE-ANALYSIS OF P53 PROTEIN IN TUMOR-TISSUES

      Saudi medical journal
    69. TSUDA H; AKIYAMA F; KUROSUMI M; SAKAMOTO G; WATANABE T
      ESTABLISHMENT OF HISTOLOGICAL CRITERIA FOR HIGH-RISK NODE-NEGATIVE BREAST-CARCINOMA FOR A MULTIINSTITUTIONAL RANDOMIZED CLINICAL-TRIAL OF ADJUVANT THERAPY

      Japanese Journal of Clinical Oncology
    70. ARDAVANIS A; SCORILAS A; LOUKERI A; GERAKINI F; PISSAKAS G; MISSITZIS I; APOSTOLIKAS N; YIOTIS I
      CATHEPSIN-D MAY HELP IN DISCRIMINATING NODE-NEGATIVE BREAST-CANCER PATIENTS AT RISK FOR LOCAL-REGIONAL RECURRENCE

      Anticancer research
    71. Muller, W; Schneiders, A; Hommel, G; Gabbert, HE
      Prognostic value of bcl-2 expression in gastric cancer

      ANTICANCER RESEARCH
    72. HUNG MC; CHANG JYJ; XING XM
      PRECLINICAL AND CLINICAL-STUDY OF HER-2 NEU-TARGETING CANCER GENE-THERAPY/

      Advanced drug delivery reviews
    73. KOGAN I; BALLINGER JR; REDSHAW R; DIAMANDIS EP; MELEGOS DN; KUBA RM; RAUTH AM
      PROSTATE-SPECIFIC ANTIGEN INDUCTION BY A STEROID-HORMONE IN T47D CELLS GROWING IN SCID MICE

      Breast cancer research and treatment
    74. Hayes, DF; Trock, B; Harris, AL
      Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful?

      BREAST CANCER RESEARCH AND TREATMENT
    75. SCHUSTERMAN MA
      THE FREE TRAM FLAP

      Clinics in plastic surgery
    76. CALDES T; INIESTA P; VEGA FJ; DEJUAN C; LOPEZ JA; DIAZRUBIO E; FERNANDEZ C; CERDAN J; BALIBREA JL; BENITO M
      COMPARATIVE SURVIVAL ANALYSIS OF P53 GENE-MUTATIONS AND PROTEIN ACCUMULATION IN COLORECTAL-CANCER

      Oncology
    77. WEIDNER N
      TUMORAL VASCULARITY AS A PROGNOSTIC FACTOR IN CANCER-PATIENTS - THE EVIDENCE CONTINUES TO GROW

      Journal of pathology
    78. ZENILMAN ME
      SURGERY IN THE ELDERLY - IN BRIEF

      Current problems in surgery
    79. GIMENEZ A; MINGUELA A; PARRILLA P; BERMEJO J; PEREZ D; MOLINA J; GARCIA AM; ORTIZ MA; ALVAREZ R; DEHARO LM
      FLOW CYTOMETRIC DNA ANALYSIS AND P53 PROTEIN EXPRESSION SHOW A GOOD CORRELATION WITH HISTOLOGIC-FINDINGS IN PATIENTS WITH BARRETTS-ESOPHAGUS

      Cancer
    80. LEE WJ; SHUN CT; HONG RL; WU MS; CHANG KJ; CHEN KM
      OVEREXPRESSION OF P53 PREDICTS SHORTER SURVIVAL IN DIFFUSE-TYPE GASTRIC-CANCER

      British Journal of Surgery
    81. DECENSI A; ROBERTSON C; ROTMENSZ N; SEVERI G; MAISONNEUVE P; SACCHINI V; BOYLE P; COSTA A; VERONESI U
      EFFECTS OF TAMOXIFEN AND TRANSDERMAL HORMONE REPLACEMENT THERAPY ON CARDIOVASCULAR RISK-FACTORS IN A PREVENTION TRIAL

      British Journal of Cancer
    82. Ferrandina, G; Scambia, G; Fagotti, A; D'Agostino, G; Panici, PB; Carbone, A; Mancuso, S
      Immunoradiometric and immunohistochemical analysis of cathepsin D in ovarian cancer: lack of association with clinical outcome

      BRITISH JOURNAL OF CANCER
    83. GORIN MB; DAY R; COSTANTINO JP; FISHER B; REDMOND CK; WICKERHAM L; GOMOLIN JES; MARGOLESE RG; MATHEN MK; BOWMAN DM; KAUFMANN D; DIMITROV NV; SINGERMAN LJ; BORNSTEIN R; WOLMARK N
      LONG-TERM TAMOXIFEN CITRATE USE AND POTENTIAL OCULAR TOXICITY

      American journal of ophthalmology
    84. VENERONI S; SILVESTRINI R; COSTA A; SALVATORI P; FARANDA A; MOLINARI R
      BIOLOGICAL INDICATORS OF SURVIVAL IN PATIENTS TREATED BY SURGERY FOR SQUAMOUS-CELL CARCINOMA OF THE ORAL CAVITY AND OROPHARYNX

      Oral Oncology
    85. PANDELIDIS SM; PETERS KL; WALUSIMBI MS; CASADY RL; LAUX SV; CAVANAUGH SH; BAUER TL
      THE ROLE OF AXILLARY DISSECTION IN MAMMOGRAPHICALLY DETECTED CARCINOMA

      Journal of the American College of Surgeons
    86. NAGUIB RNG; SHERBET GV
      ARTIFICIAL NEURAL NETWORKS IN CANCER-RESEARCH

      Pathobiology
    87. FARANDA A; COSTA A; CANOVA S; ABOLAFIO G; SILVESTRINI R
      IMAGE AND FLOW CYTOMETRIC ANALYSES OF DNA CONTENT IN HUMAN SOLID TUMORS - A COMPARATIVE-STUDY

      Analytical and quantitative cytology and histology
    88. COSTA A; DOCI R; MOCHEN C; BIGNAMI P; FARANDA A; GENNARI L; SILVESTRINI R
      CELL PROLIFERATION-RELATED MARKERS IN COLORECTAL LIVER METASTASES - CORRELATION WITH PATIENT PROGNOSIS

      Journal of clinical oncology
    89. RAYBAUDDIOGENE H; FORTIN A; MORENCY R; ROY J; MONTEIL RA; TETU B
      MARKERS OF RADIORESISTANCE IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK - A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY

      Journal of clinical oncology
    90. IWAYA K; TSUDA H; FUKUTOMI T; TSUGANE S; SUZUKI M; HIROHASHI S
      HISTOLOGIC GRADE AND P53 IMMUNOREACTION AS INDICATORS OF EARLY RECURRENCE OF NODE-NEGATIVE BREAST-CANCER

      Japanese Journal of Clinical Oncology
    91. DEMETS DL
      DISTINCTIONS BETWEEN FRAUD, BIAS, ERRORS, MISUNDERSTANDING, AND INCOMPETENCE

      Controlled clinical trials
    92. VERMEULEN PB; LIBURA M; LIBURA J; ONEILL PJ; VANDAM P; VANMARCK E; VANOOSTEROM AT; DIRIX LY
      INFLUENCE OF INVESTIGATOR EXPERIENCE AND MICROSCOPIC FIELD SIZE ON MICROVESSEL DENSITY IN NODE-NEGATIVE BREAST-CARCINOMA

      Breast cancer research and treatment
    93. MELTZER D
      ACCOUNTING FOR FUTURE COSTS IN MEDICAL COST-EFFECTIVENESS ANALYSIS

      Journal of health economics
    94. MULLERHOCKER J; OBERNITZ N; JOHANNES A; LOHRS U
      P53 GENE-PRODUCT AND EGF-RECEPTOR ARE HIGHLY EXPRESSED IN PLACENTAL SITE TROPHOBLASTIC TUMOR

      Human pathology
    95. DIAMANDIS EP
      CLINICAL-APPLICATIONS OF TUMOR-SUPPRESSOR GENES AND ONCOGENES IN CANCER

      Clinica chimica acta
    96. LONARDO F; UEDA T; HUVOS AG; HEALY J; LADANYI M
      P53 AND MDM2 ALTERATIONS IN OSTEOSARCOMAS - CORRELATION WITH CLINICOPATHOLOGICAL FEATURES AND PROLIFERATIVE RATE

      Cancer
    97. DETTMAR P; HARBECK N; THOMSSEN C; PACHE L; ZIFFER P; FIZI K; JANICKE F; NATHRATH W; SCHMITT M; GRAEFF H; HOFLER H
      PROGNOSTIC IMPACT OF PROLIFERATION-ASSOCIATED FACTORS MIBI (KI-67) AND S-PHASE IN NODE-NEGATIVE BREAST-CANCER

      British Journal of Cancer
    98. BLAND KI
      ADVANCES IN MOLECULAR-GENETICS

      The American journal of surgery
    99. CHAN HSL; LING V
      ANTI-P-GLYCOPROTEIN ANTIBODY C219 CROSS-REACTIVITY WITH C-ERBB2 PROTEIN - DIAGNOSTIC AND CLINICAL IMPLICATIONS

      Journal of the National Cancer Institute
    100. COSTANTINO JP; KULLER LH; IVES DG; FISHER B; DIGNAM J
      CORONARY HEART-DISEASE MORTALITY AND ADJUVANT TAMOXIFEN THERAPY

      Journal of the National Cancer Institute


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/01/21 alle ore 13:04:59